National Cancer Institute U.S. National Institutes of Health www.cancer.gov

CHTN Logo Cooperative Human Tissue Network

CHTN Home | Admin Login

Investigator Application Requirements and Priority

In order to receive CHTN biospecimens, Investigators must submit a completed CHTN Application[DOC], signed copy of the Data Use Agreement and a copy of your Institutional Review Board letter of approval, exemption or review to use human biospecimens for your project to your primary division. An investigator will need to provide the following:

Once you provide the completed forms and documentation, a surgical pathologist will review your requests to determine feasibility.

Tissues are provided on a rotating basis and given a priority as follows:

The CHTN seeks to provide tissues to the widest group of investigators practicable. In this regard no investigator should expect to have access to unlimited numbers of malignant specimens of one type.

The CHTN makes every effort to tailor our services to the needs of each investigator. It is advisable to discuss your request(s) with the CHTN to ensure the best results. The CHTN can provide information about the availability of services, help refine requests, ensure access to the greatest number of suitable biospecimens and provide guidance through the application process. Please use our Lead Investigator Form to discuss your needs.

The NCI Tissue Expeditor or NCI Specimen Resource Locator External Web Site Policy can be contacted if you require large numbers of specimens and/or extensive patient data.

[DOC]Documents in DOC format require Microsoft Word® or Microsoft Word Viewer®. If you experience problems with DOC documents, please download Word Viewer®.